Skip to content

A study comparing two treatments for early stage knee osteoarthritis: injection of platelet rich plasma and new type hyaluronic acid using ultrasound to see which treatment works better for pain relief and knee joint function

Clinical and functional outcomes of early stage knee osteoarthritis with two different modalities of treatment- intraarticular single platelet rich plasma versus novel cross linked hyaluronic acid under ultrasound guidance. - NIL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/03/081895
Enrollment
60
Registered
2025-03-07
Start date
Unknown
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M179- Osteoarthritis of knee, unspecified

Interventions

Intervention1: Ultrasound guided high molecular weight hyaluronic acid injection for early stage knee osteoarthritis: Single dose injection of high molecular weight hyaluronic acid injection containi

Sponsors

Dr S Ravindran
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Diagnosis of primary knee osteoarthritis Kellgren-Lawrence grade less than 3

Exclusion criteria

Exclusion criteria: Age less than 50 years Kellgren-Lawrence more than or equal to 3 History or active presence of clinically significant inflammatory articular or rheumatic disease other than osteoarthritis Rapidly progressive osteoarthritis before the start of trial History of lower extremity surgery Excessive mechanical axis deviation varus more than 5 degree, valgus more than 5 degree Body mass index more than 30 History or presence of malignant disorders systemic disorders, such as diabetes mellitus, severe cardiovascular diseases, hematologic diseases, immune-deficiencies, and infections Systematic or intra-articular corticosteroid therapy in the previous 3 months Prior treatment with HA in the past 6 months Anticoagulants or antiaggregant therapy in the preceding 30 days Nonsteroidal anti inflammatory medications in the preceding 7 days Platelet count less than 150000 per mL Hemoglobin less than 12 gram per dL

Design outcomes

Primary

MeasureTime frame
The objective is to assess the change in Western Ontario McMaster Universities Osteoarthritis Index score which includes pain, stiffness and physical functionTimepoint: At 0, 1, and 3 months

Secondary

MeasureTime frame
NILTimepoint: NIL

Countries

India

Contacts

Public ContactDr S Ravindran

Institute of Anaesthesiology, Government Rajaji Hospital & Madurai medical college, Madurai

drthendral29@gmail.com9842188722

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026